Article
Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs.
PLoS genetics - 1 Apr 2018
Mount Harley O'Connor, Revie Nicole M, Todd Robert T, Anstett Kaitlin, Collins Cathy, Costanzo Michael, Boone Charles, Robbins Nicole, Selmecki Anna, Cowen Leah E
Abstract excerpt
Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the...
Topics
- Antifungal Agents
- Azoles
- Candida albicans
- Drug Resistance, Fungal
- GTPase-Activating Proteins
- Host-Pathogen Interactions
- Humans
- Microbial Sensitivity Tests
- Mutation
- Mycoses
